Recent News

Our attorneys regularly update this section to bring you the latest news in recalled devices, mass tort litigation progress and a wide variety of critical information about dangerous products for consumers. If you have a question about any of the topics, simply contact us or click on any of the images below and leave a comment. We welcome your thoughts and questions!

Toxic Chemicals Still Found in Many Common Cosmetics

by Brenda Fulmer | May 31, 2018 | Common Questions, Mass Tort News

The U.S. Food and Drug Administration’s (FDA) slow and retroactive response to toxic chemicals found in cosmetics is being called into question. In the past year, there have been more protests urging the FDA to ban lead acetate, a compound found in hair dyes. It was...

United States Judicial Panel on Multidistrict Litigation: November Meeting Overview

by Brenda Fulmer | Dec 1, 2017 | Announcement, Hot Topics, Mass Tort News

The next hearing session of the United States Judicial Panel on Multidistrict Litigation is scheduled for November 30, 2017 in St. Louis, Missouri. Eight matters are set for oral argument to consider motions to transfer each to one centralized district for coordinated...

Surgeons are Finally Tuning in to Stryker Trunnion Failure Cases

by Cal Warriner | Oct 10, 2017 | Articles

We have been investigating Stryker trunnion failure cases since 2012. During our involvement in Stryker Rejuvenate and ABG II stem failures and subsequent recall we began receiving inquiries into Stryker monoblock stem trunnion failures. At first glance it appeared...

Patients Face Firmware Updates To Prevent Pacemaker Hacking

by Brenda Fulmer | Sep 28, 2017 | Articles, Defective Medical Devices

Almost half a million pacemakers implanted in patients with heart disease have been recalled because of a scary and shocking scenario: The life-saving devices could be tampered with remotely by computer hackers - pacemaker hacking is becoming a possibility. The U.S....

Thousands of Victims Left in Wake of Disastrous Medtronic Infuse Product

by Brenda Fulmer | Sep 12, 2017 | Defective Medical Devices, Hot Topics

Please note: At this time, the dangerous drug attorneys at Searcy Denney are not accepting cases for injuries from the Medtronic Infuse Bone Graft. If you or a loved one has suffered injuries by another dangerous drug or medical device, we are always available to...

Viagra and Cialis MDL Litigation Update

by Brenda Fulmer | Sep 5, 2017 | Articles, Hot Topics

In April of 2016, the Judicial Panel on Multidistrict Litigation, a panel who determines whether to coordinate federal court lawsuits into multidistrict litigation (MDL), centralized lawsuits involving men who developed melanoma after ingesting Viagra. This MDL was...

Zimmer Implantable Spinal Fusion Stimulator Recall

by Brenda Fulmer | Aug 16, 2017 | Articles, Defective Medical Devices

The FDA announced a recall of Zimmer Biomet’s SpF PLUS Mini and SpF XL IIb implantable spinal fusion stimulators. This is due to the high levels of potentially harmful chemicals that are potentially harmful to tissues and organs (cytotoxicity). The recall of the...

New Jersey Stryker LFit V40 Lawsuits Receive Consolidation

by Cal Warriner | Jun 19, 2017 | Defective Medical Devices, Hot Topics, Mass Tort News

On August 29, 2016, Stryker issued a voluntary recall of certain lots of Stryker LFit Anatomic Cobalt Chromium V40 femoral heads, a prosthetic hip replacement device, manufactured before March 2011. This recall included over 40,000 defective hips. Stryker cited to...

Finally – Victims of Stryker’s Latest Recall Receiving Notice

by Cal Warriner | May 31, 2017 | Defective Medical Devices, Hot Topics, Rejuvenate/ABG II

Lawsuits have been filed against Stryker since 2013 alleging that its line of TMZF hip replacement stems are a danger when combined with metal femoral heads. However, patients who have received this potentially dangerous combination of products are just now being...

Invokana Under New Scrutiny as FDA Publishes Further Research

by Brenda Fulmer | May 25, 2017 | Articles, Defective Drugs

Janssen Pharmaceuticals’ type 2 diabetes medication is under new scrutiny. This new scrutiny follows confirmation from the Food and Drug Administration (FDA) that use of the drug canagliflozin, sold as Invokana and Invokamet, potentially increases the risk of...